ABCLONAL SCIENCE, INC

ABCLONAL SCIENCE, INC specializes in the synthesis of custom monoclonal antibodies and gene-based biological reagents for research and therapeutic applications. Their core capabilities center on high-precision gene synthesis, recombinant protein expression, and antibody development workflows, enabling the production of sequence-defined, non-diagnostic biological products. The company demonstrates technical proficiency in molecular cloning, codon optimization, and recombinant expression systems critical for generating research-grade antibodies with high specificity and batch consistency. Their work supports downstream applications in immunology, target validation, and preclinical drug development, distinguishing itself through rigorous quality control in synthetic biology pipelines and rapid turnaround for complex protein constructs. The contractor has delivered services exclusively to the Department of Health and Human Services, primarily supporting biomedical research initiatives requiring custom antibody reagents. This relationship suggests alignment with NIH-funded programs or CDC-led projects focused on infectious disease, oncology, or immunological therapeutics, where precise molecular tools are essential for experimental reproducibility and translational research. Their primary industry focus is biological product manufacturing under NAICS 325414, which encompasses the production of therapeutic and research-grade biologicals excluding diagnostic kits. This positions ABCLONAL SCIENCE, INC within the life sciences supply chain as a specialized provider of synthetic biological components, serving academic, government, and biopharma research environments that demand tailored antibody solutions not commercially available. As a small business structured as a 2L entity based in Woburn, Massachusetts, ABCLONAL SCIENCE, INC operates with a focused, agile model typical of specialized biotech suppliers. The company holds no federal certifications, but its technical work aligns with federal research standards for biosafety and reproducibility. Its geographic presence in the Greater Boston biotech corridor supports access to academic partnerships and federal research institutions, reinforcing its niche role in the government-funded life sciences ecosystem.